Pancreatic Cancer Research

ResearcherThe University of Texas Southwestern Medical CenterNo recent work listed

Ali A. Mokdad

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2551-2104; OpenAlex author ID A5101970328. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper

Papers 2

  1. Comparison of Overall Survival Between Preoperative Chemotherapy and Chemoradiotherapy for Resectable Pancreatic Adenocarcinoma. Co-author DOI 10.6004/jnccn.2018.7068↗
  2. Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis. Co-author DOI 10.1200/jco.2016.68.5081↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. John C. Mansour · 2 shared papers, 2017–2018 · strength 0.15
  2. Patricio Marcelo Polanco · 2 shared papers, 2017–2018 · strength 0.15
  3. Adam Charles Yopp · 2 shared papers, 2017–2018 · strength 0.15
  4. Matthew R. Porembka · 2 shared papers, 2017–2018 · strength 0.15
  5. Sam C. Wang · 2 shared papers, 2017–2018 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.